Breaking through spasticity in Multiple Sclerosis using Direct Current (Neubie) UK leading clinic
- contactapexneuro
- 3 days ago
- 2 min read
One of the most common Multiple Sclerosis symptoms we work with is spasticity. Many of our clients have tried pharmaceutical interventions with limited success, and this especially common in clients who have had HSCT therapy, who can experience an increase in spasticity, clonus and muscle tone.
We see substantial improvement both in the clinic utilising the Neubie (Direct Current therapy) as the UK's first and most experienced practitioners, and at home via our Remote programme. We have found that using Direct Current we are able to help clients manage and regain control over movement without the limitations of spasticity, all without the need for invasive methods. For our Remote Support Programme, we utilise a handheld device that can be easily set up and used in any location to make managing spasticity easy and efficient.
RESEARCH: Inhibiting Spasticity & Improving Functional Outcomes in Individuals with Multiple Sclerosis
The Neubie Device uses direct current electrical stimulation to communicate with mechanoreceptors of the peripheral nervous system (PNS). This action supports functional changes for a variety of FDA cleared indications, including neuromuscular re-education, reducing spasms, and increasing range of motion. Multiple Sclerosis (MS) has a high incidence of spasticity and motor deficits. This case series assessed the efficacy of the Neubie as a therapeutic intervention for spasticity and function in 7 MS diagnosed participants with Expanded Disability Status Scale (EDSS) scores of 6-8.
Why Use the Neubie to Manage Symptoms Related to MS?
Multiple Sclerosis (MS) has a high incidence of debilitating spasticity. Central Nervous System (CNS) intrafusal settings have an impact on spasticity level. Mechanoreceptors of the Peripheral Nervous System (PNS) communicate monosynaptically with the central nervous system (CNS). The Neubie can be used to create inputs that result in changes to the PNS and CNS for improved management of motor dysfunction in neurological conditions like MS.